Cover Image
Market Research Report

Infectious Disease Drugs: The Chinese Market

Published by BCC Research Product code 474942
Published Content info 164 Pages
Immediate Delivery Available
Price
Back to Top
Infectious Disease Drugs: The Chinese Market
Published: March 16, 2017 Content info: 164 Pages
Description

The Chinese infectious disease drugs market reached $32.2 billion in 2016. The market should reach $61.7 billion by 2021, growing at a compound annual growth rate (CAGR) of 13.9% from 2016 to 2021.

Report Includes

  • An overview of the Chinese market for infectious disease drugs.
  • Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
  • Discussion of the increasing concern regarding antibiotic-resistant organisms and their sometimes-fatal effects on humans.
  • Examination of technological developments, future trends, and emerging opportunities.
  • Assessments of the current state of infectious diseases on a global basis, broken down by type of disease (i.e., bacterial, viral, parasitic, and fungal) and appropriate treatments, both current and anticipated, and by geographic region.
  • Profiles of major players in the field of infectious disease treatments.

Report Scope

The scope of the report includes infectious disease drugs applications, industries, markets and companies in China. The markets for infectious disease drugs are given for the years 2015, 2016 and 2021.

The report covers the Chinese market for both communicable and noncommunicable infectious disease drugs. In this report, communicable infectious diseases only refer to the 39 statutory communicable diseases stated by the National Health and Family Planning Commission of the People's Republic of China (NHFPC). They include viral hepatitis, pulmonary tuberculosis, syphilis, bacillary/amebic dysentery, gonorrhea, scarlet fever, brucellosis, acquired immunodeficiency syndrome (AIDS), hand-foot-and-mouth disease, infectious diarrhea, influenza, and epidemic parotitis.

In this report, China is referred to as Mainland China. It does not include Hong Kong, Macao and Taiwan. Mainland China has a total of 31 province-level regions, including 22 provinces, four province-level municipalities (cities) and five province-level autonomous regions. Important geographic markets will be discussed, including Beijing, Shanghai, Guangdong and others.

More than 100 Chinese companies in the infectious disease drug industry are profiled in this report.

Analyst Credentials

Jason Chen has been an analyst and consultant for the polymer, composite, fiber, textile and energy industries for 15 years. He works as a researcher, writer and/or editor for the American Composites Manufacturers Association (ACMA), China Textile Academy (CTA), China Chemical Fiber Association (CCFA), International Fiber Journal, Filtration News, Platts Emission Daily, Vision Systems Design, Pesticide and Toxic Chemical News and MobileTex. Currently he is the chief scientist of a company endeavoring to reduce China's air and water pollution. He has a degree in Civil Engineering, Chemicals and Advanced Materials from Shantou University.

Table of Contents
Product Code: PHM178A

Table of Contents

CHAPTER 1 INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • SCOPE OF REPORT
  • INTENDED AUDIENCE
  • METHODOLOGY
  • INFORMATION SOURCES
  • ANALYSTS' CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 SUMMARY

  • SUMMARY TABLE VALUE OF CHINESE INFECTIOUS DISEASE DRUG MARKET, BY DISEASE TYPE, THROUGH 2021 ($ MILLIONS)
  • SUMMARY FIGURE VALUE OF CHINESE INFECTIOUS DISEASE DRUG MARKET, BY DISEASE TYPE, 2015-2021 ($ MILLIONS)
  • LARGEST AND FASTEST-GROWING MARKETS
    • LARGEST INFECTIOUS DISEASE DRUG MARKETS
    • FAST-GROWING INFECTIOUS DISEASE DRUG MARKETS
  • LAWS, REGULATIONS AND TARGETS
    • PHARMACEUTICAL ADMINISTRATION LAW OF THE PEOPLE'S REPUBLIC OF CHINA
    • PROCUREMENT AND BIDDING MANAGEMENT OF THE CHINA FOOD AND DRUG ADMINITRATION
    • ADMINISTRATIVE MEASURES FOR THE CLINICAL USE OF ANTIBACTERIAL DRUGS
    • LIMITATION OF ANTIBACTERIAL DRUGS

CHAPTER 3 THE CHINESE DRUG MARKET

  • CHINESE DRUG MARKET BY SALES CHANNELS
  • TABLE 1 VALUE OF CHINESE DRUG END-CONSUMER MARKET, BY SALES CHANNELS, THROUGH 2021 ($ MILLIONS)
  • FIGURE 1 VALUE OF CHINESE DRUG END-CONSUMER MARKET, BY SALES CHANNELS, 2015-2021 ($ MILLIONS)
    • SUPPLY CHAIN AND PRICING STRUCTURE
    • FIGURE 2 DRUG SUPPLY CHAIN IN CHINA
      • Hospitals
      • Retailers
    • RETAIL MARKET
      • Chinese Drug Retail Market by Drug Type
      • TABLE 2 VALUE OF THE CHINESE DRUG MARKET BY RETAIL CHANNEL BY DRUG TYPE, THROUGH 2021 ($ MILLIONS)
      • Chinese Traditional Drugs in the Retail Market
      • TABLE 3 CHINESE RETAIL TRADITIONAL DRUGS SALES BY MAJOR DRUG TYPE, 2015 ($ MILLIONS/%)
      • TABLE 4 CHINESE RETAIL TRADITIONAL PATENT DRUG SALES BY DRUG TYPE, 2015 ($ MILLIONS/%)
      • Chemical and Biological Drugs in the Chinese Retail Market
      • TABLE 5 CHINESE RETAIL CHEMICAL AND BIOLOGICAL DRUG SALES BY DRUG TYPE, 2015 ($ MILLIONS/%)
      • Chinese Retail Market by Drug Stores
      • TABLE 6 CHINESE DRUG RETAIL SALES BY RETAIL COMPANY, 2015 ($ MILLIONS/%)
      • Chinese Hospital Drug Market
      • TABLE 7 VALUE OF THE CHINESE DRUG MARKET IN HOSPITALS, BY DRUG TYPE, THROUGH 2021 ($ MILLIONS)
        • Chinese Traditional Drugs Sold in Hospitals
        • TABLE 8 MARKET SHARES OF CHINESE TRADITIONAL DRUGS SOLD IN HOSPITALS, BY HOSPITAL TYPE AND DRUG TYPE, 2015 (%)
        • TABLE 9 MARKET VALUES OF CHINESE TRADITIONAL DRUGS SOLD IN HOSPITALS, BY HOSPITAL TYPE AND DRUG TYPE, 2015 ($ MILLIONS)
        • TABLE 10 MARKET VALUES OF CHINESE TRADITIONAL DRUGS SOLD IN HOSPITALS, BY HOSPITAL TYPE, THROUGH 2021 ($ MILLIONS)
        • Chemical and Biological Drugs Sold in Hospitals
        • TABLE 11 MARKET SHARES OF CHEMICAL AND BIOLOGICAL DRUGS SOLD IN HOSPITALS BY HOSPITAL TYPE AND DRUG TYPE, 2015 (%)
        • TABLE 12 MARKET VALUE OF CHEMICAL AND BIOLOGICAL DRUGS SOLD IN HOSPITALS IN 2015 BY HOSPITAL TYPE AND DRUG TYPE ($ MILLIONS)
        • TABLE 13 MARKET VALUES OF CHEMICAL AND BIOLOGICAL DRUGS SOLD IN HOSPITALS BY HOSPITAL TYPE, THROUGH 2021 ($ MILLIONS)
  • CHINESE DRUG MARKET BY DRUG TYPE
  • TABLE 14 VALUE OF THE CHINESE DRUG MARKET BY DRUG TYPE, THROUGH 2021 ($ MILLIONS)
    • THE CHINESE TRADITIONAL DRUG MARKET BY MAJOR SALES CHANNELS
    • TABLE 15 VALUE OF CHINESE TRADITIONAL DRUGS BY SALES CHANNELS THROUGH 2021 ($ MILLIONS)
    • THE CHINESE CHEMICAL AND BIOLOGICAL DRUG MARKET BY MAJOR SALES CHANNELS
    • TABLE 16 VALUE OF CHINESE CHEMICAL AND BIOLOGICAL DRUGS BY SALES CHANNELS, THROUGH 2021 ($ MILLIONS)

CHAPTER 4 CHINESE INFECTIOUS DISEASE DRUG MARKET BY DISEASE

  • TABLE 17 VALUE OF THE CHINESE INFECTIOUS DISEASE DRUG MARKET BY DISEASE TYPE, THROUGH 2021 ($ MILLIONS)
  • FIGURE 3 VALUE OF THE CHINESE COMMUNICABLE INFECTIOUS DISEASE DRUG MARKET BY MAJOR DISEASE TYPE, 2015-2021 ($ MILLIONS)
  • MOST COMMON 39 COMMUNICABLE DISEASES
  • TABLE 18 VALUE OF THE CHINESE COMMUNICABLE INFECTIOUS DISEASE DRUG MARKET BY MAJOR DISEASE TYPE, THROUGH 2021 ($ MILLIONS)
  • FIGURE 4 VALUE OF THE CHINESE COMMUNICABLE INFECTIOUS DISEASE DRUG MARKET BY MAJOR DISEASE TYPE, 2015-2021 ($ MILLIONS)
    • COMMUNICABLE DISEASES IN CHINA
    • TABLE 19 NUMBER OF COMMUNICABLE DISEASES BY MAJOR TYPE IN CHINA, 2015
      • Category A Communicable Diseases
      • TABLE 20 NUMBER OF CHINESE CATEGORY-A COMMUNICABLE DISEASES BY MAJOR DISEASE, 2015
      • Category B Communicable Diseases
      • TABLE 21 NUMBER OF CHINESE CATEGORY B COMMUNICABLE DISEASES BY MAJOR DISEASE, 2015
      • Category C Communicable Diseases
      • TABLE 22 NUMBER OF CHINESE CATEGORY C COMMUNICABLE DISEASES BY MAJOR DISEASE, 2015
      • History
    • THE CHINESE COMMUNICABLE DISEASE DRUG MARKET BY DISEASE TYPE
      • Viral Hepatitis
      • TABLE 23 VALUE OF CHINESE VIRAL HEPATITIS DRUG MARKET BY MAJOR TYPE, 2015 ($ MILLIONS/%)
      • Pulmonary Tuberculosis
      • TABLE 24 VALUE OF CHINESE PULMONARY TUBERCULOSIS DRUG MARKET BY MAJOR TYPE, 2015 ($ MILLIONS/%)
      • AIDS
      • Infective Keratitis and Conjunctivitis
      • TABLE 25 VALUE OF CHINESE INFECTIVE KERATITIS/CONJUNCTIVITIS DRUG MARKET BY MAJOR DRUG TYPE, 2015 ($ MILLIONS/%)
  • OTHER INFECTIOUS DISEASES
    • ACINETOBACTER INFECTIONS
    • ACTINOMYCOSIS
    • AMOEBIASIS
    • ANTHRAX
    • ASPERGILLOSIS
    • BACTERIAL PNEUMONIA
    • VIRAL PNEUMONIA

CHAPTER 5 CHINESE INFECTIOUS DISEASE DRUG MARKET BY PRODUCTS

  • TOP 30 AND TOP 100 INFECTIOUS DISEASE DRUGS IN CHINA
  • TABLE 26 VALUE OF THE CHINESE INFECTIOUS DISEASE DRUG MARKET BY MAJOR PRODUCT, THROUGH 2021 ($ MILLIONS)
  • FIGURE 5 VALUE OF THE CHINESE COMMUNICABLE INFECTIOUS DISEASE DRUG MARKET BY MAJOR DISEASE TYPE, 2015-2021 ($ MILLIONS)
  • TABLE 27 VALUE OF THE CHINESE INFECTIOUS DISEASE DRUG MARKET BY MAJOR PRODUCT, THROUGH 2021 ($ MILLIONS)
    • ENTECAVIR
      • Chinese Entecavir Market by Sales Channels
      • TABLE 28 VALUE OF CHINESE ENTECAVIR MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
      • FIGURE 6 VALUE OF CHINESE ENTECAVIR MARKET BY SALES CHANNEL, 2015 (%)
      • Chinese Entecavir Market by Manufacturers
      • TABLE 29 CHINESE ENTECAVIR MARKET BY SALES CHANNEL AND LEADING SUPPLIER, 2015 (%)
      • TABLE 30 VALUE OF CHINESE ENTECAVIR MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
    • PIPERACILLIN-TAZOBACTAM (INJECTION)
    • TABLE 31 VALUE OF CHINESE INJECTIVE PIPERACILLIN-TAZOBACTAM MARKET, BY SALES CHANNEL, 2015 ($ MILLIONS/%)
    • FIGURE 7 VALUE OF CHINESE INJECTIVE PIPERACILLIN-TAZOBACTAM MARKET, BY SALES CHANNEL, 2015 (%)
    • MEROPENEM (INJECTION)
      • Chinese Meropenem Market by Sales Channels
      • TABLE 32 VALUE OF CHINESE INJECTIVE MEROPENEM MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
      • FIGURE 8 VALUE OF CHINESE INJECTIVE MEROPENEM MARKET BY SALES CHANNEL, 2015 (%)
      • Chinese Meropenem Market by Drugmakers
      • TABLE 33 VALUE OF CHINESE MEROPENEM MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
    • CEFPERAZONE-SULBACTAM (INJECTION)
      • Chinese Cefperazone-Sulbactam Market by Sales Channels
      • TABLE 34 VALUE OF CHINESE INJECTIVE CEFPERAZONE-SULBACTAM MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
      • FIGURE 9 VALUE OF CHINESE INJECTIVE CEFPERAZONE-SULBACTAM MARKET BY SALES CHANNEL, 2015 (%)
      • Chinese Cefperazone-Sulbactam Market by Drugmakers
      • TABLE 35 VALUE OF CHINESE INJECTIVE CEFPERAZONE-SULBACTAM MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
    • LEVOFLOXACIN (INJECTION)
    • TABLE 36 VALUE OF CHINESE LEVOFLOXACIN MARKET BY DRUG FORM, 2015 ($ MILLIONS/%)
      • Chinese Levofloxacin Market by Sales Channels
      • Injective Levofloxacin
      • TABLE 37 VALUE OF CHINESE INJECTIVE LEVOFLOXACIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
      • FIGURE 10 VALUE OF CHINESE INJECTIVE LEVOFLOXACIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
      • Oral Levofloxacin
      • TABLE 38 VALUE OF CHINESE ORAL LEVOFLOXACIN TABLET MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
      • Chinese Injective Levofloxacin Market by Drugmakers
      • TABLE 39 VALUE OF CHINESE INJECTIVE LEVOFLOXACIN MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
    • CEFOPERAZONE-TAZOBACTAM (INJECTION)
    • TABLE 40 VALUE OF CHINESE INJECTIVE CEFOPERAZONE-TAZOBACTAM MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
    • FIGURE 11 VALUE OF CHINESE INJECTIVE CEFOPERAZONE-TAZOBACTAM MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
    • CEFUROXIMEE (INJECTION)
    • TABLE 41 VALUE OF CHINESE CEFUROXIMEE MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
    • TABLE 42 VALUE OF CHINESE INJECTIVE CEFUROXIMEE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
    • FIGURE 12 VALUE OF CHINESE INJECTIVE CEFUROXIME MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
    • CEFOTIAM (INJECTION)
      • Chinese Cefotiam Market by Sales Channels
      • TABLE 43 VALUE OF CHINESE INJECTIVE CEFOTIAM MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
      • FIGURE 13 VALUE OF CHINESE INJECTIVE CEFOTIAM MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
      • Chinese Injective Cefotiam Market by Drugmakers
      • TABLE 44 VALUE OF CHINESE CEFOTIAM MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
    • CEFATHIAMIDINE (INJECTION)
      • Chinese Cefathiamidine Market by Sales Channels
      • TABLE 45 VALUE OF CHINESE INJECTIVE CEFATHIAMIDINE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
      • FIGURE 14 VALUE OF CHINESE INJECTIVE CEFATHIAMIDINE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
      • Chinese Injective Cefathiamidine Market by Drugmakers
      • TABLE 46 VALUE OF CHINESE CEFATHIAMIDINE MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
    • IMIPENEM-CILASTATIN (INJECTION)
      • Chinese Imipenem/Cilastatin Market by Sales Channels
      • TABLE 47 VALUE OF CHINESE INJECTIVE IMIPENEM/CILASTATIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
      • FIGURE 15 VALUE OF CHINESE INJECTIVE IMIPENEM/CILASTATIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
      • Chinese Injective Imipenem/Cilastatin Market by Drugmakers
      • TABLE 48 VALUE OF CHINESE IMIPENEM/CILASTATIN MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
    • VORICONAZOLE (INJECTION)
    • TABLE 49 VALUE OF CHINESE VORICONAZOLE MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
      • Chinese Injective Voriconazole Market by Sales Channels
      • TABLE 50 VALUE OF CHINESE INJECTIVE VORICONAZOLE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
      • FIGURE 16 VALUE OF CHINESE INJECTIVE VORICONAZOLE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
      • Chinese Injective Voriconazole Market by Drugmakers
      • TABLE 51 VALUE OF CHINESE VORICONAZOLE MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
    • MOXIFLOXACIN (INJECTION AND TABLETS)
    • TABLE 52 VALUE OF CHINESE MOXIFLOXACIN MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
      • Chinese Moxifloxacin Market by Sales Channels
      • TABLE 53 VALUE OF CHINESE MOXIFLOXACIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
      • FIGURE 17 VALUE OF CHINESE MOXIFLOXACIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
      • Chinese Moxifloxacin Market by Drugmakers
      • TABLE 54 VALUE OF CHINESE MOXIFLOXACIN MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
    • CEFOXITIN (INJECTION)
      • Chinese Injective Cefoxitin Market by Sales Channels
      • TABLE 55 VALUE OF CHINESE INJECTIVE CEFOXITIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
      • FIGURE 18 VALUE OF CHINESE INJECTIVE CEFOXITIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
      • Chinese Injective Cefoxitin Market by Drugmakers
      • TABLE 56 VALUE OF CHINESE CEFOXITIN MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
    • LATAMOXEF (INJECTION)
      • Chinese Injective Latamoxef Market by Sales Channels
      • TABLE 57 VALUE OF CHINESE INJECTIVE LATAMOXEF MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
      • FIGURE 19 VALUE OF CHINESE INJECTIVE LATAMOXEF MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
      • Chinese Injective Latamoxef Market by Drugmakers
      • TABLE 58 VALUE OF CHINESE INJECTIVE LATAMOXEF MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
    • CEFTRIAXONE (INJECTION)
      • Chinese Injective Ceftriaxone Market by Sales Channels
      • TABLE 59 VALUE OF CHINESE INJECTIVE CEFTRIAXONE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
      • FIGURE 20 VALUE OF CHINESE INJECTIVE CEFTRIAXONE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
      • Chinese Injective Ceftriaxone Market by Drugmakers
      • TABLE 60 VALUE OF CHINESE CEFTRIAXONE MARKET BY PRODUCER, 2015 ($ MILLIONS/%)
    • ADEFOVIR
      • Chinese Adefovir Market by Sales Channels
      • TABLE 61 VALUE OF CHINESE ADEFOVIR MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
      • FIGURE 21 VALUE OF CHINESE ADEFOVIR MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
      • Chinese Adefovir Market by Manufacturers
      • TABLE 62 CHINESE ADEFOVIR MARKET SHARE BY SALES CHANNEL AND LEADING SUPPLIER, 2015 (%)
      • TABLE 63 VALUE OF CHINESE ADEFOVIR MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
    • LAMIVUDINE
      • Chinese Lamivudine Market by Sales Channels
      • TABLE 64 VALUE OF CHINESE LAMIVUDINE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
      • FIGURE 22 VALUE OF CHINESE LAMIVUDINE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
      • Chinese Lamivudine Market by Manufacturers
      • TABLE 65 CHINESE LAMIVUDINE MARKET SHARE BY SALES CHANNEL AND LEADING SUPPLIER, 2015 (%)
      • TABLE 66 VALUE OF CHINESE LAMIVUDINE MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
    • CEFAZOLIN (INJECTION)
      • Chinese Injective Cefazolin Market by Sales Channels
      • TABLE 67 VALUE OF CHINESE INJECTIVE CEFAZOLIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
      • FIGURE 23 VALUE OF CHINESE INJECTIVE CEFAZOLIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
      • Chinese Injective Cefazolin Market by Drugmakers
      • TABLE 68 VALUE OF CHINESE CEFAZOLIN MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
    • CEFTAZIDIME (INJECTION)
    • TABLE 69 VALUE OF CHINESE CEFAZOLIN MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
      • Chinese Injective Ceftazidime Market by Sales Channels
      • TABLE 70 VALUE OF CHINESE INJECTIVE CEFTAZIDIME MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
      • FIGURE 24 VALUE OF CHINESE INJECTIVE CEFTAZIDIME MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
      • Chinese Injective Ceftazidime Market by Drugmakers
      • TABLE 71 VALUE OF CHINESE CEFTAZIDIME MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
    • TELBIVUDINE
    • TABLE 72 VALUE OF CHINESE TELBIVUDINE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
    • FIGURE 25 VALUE OF CHINESE TELBIVUDINE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
    • OTHER DRUGS
      • Cefixime
      • TABLE 73 VALUE OF CHINESE CEFIXIME MARKET BY DRUG FORM, 2015 ($ MILLIONS/%)
      • TABLE 74 VALUE OF CHINESE CEFIXIME MARKET BY SALES CHANNELS, 2015 ($ MILLIONS/%)
      • Amoxicillin-Clavulanate
      • TABLE 75 VALUE OF CHINESE AMOXICILLIN-CLAVULANATE MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
      • Itraconazole
      • TABLE 76 VALUE OF CHINESE ITRACONAZOLE MARKET BY DRUG FORMS, 2015 ($ MILLIONS/%)
      • TABLE 77 VALUE OF CHINESE ITRACONAZOLE MARKET BY SALES CHANNELS, 2015 ($ MILLIONS/%)
      • Cefaclor
      • TABLE 78 VALUE OF CHINESE CEFACLOR MARKET BY DRUG FORMS, 2015 ($ MILLIONS/%)
      • TABLE 79 VALUE OF CHINESE CEFACLOR MARKET BY SALES CHANNELS, 2015 ($ MILLIONS/%)
      • Vidarabine (Injection)
        • Chinese Vidarabine Market by Sales Channels
        • TABLE 80 VALUE OF CHINESE VIDARABINE INJECTION MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
        • FIGURE 26 VALUE OF CHINESE VIDARABINE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
        • Chinese Vidarabine Market by Manufacturers
        • TABLE 81 CHINESE VIDARABINE MARKET SHARE BY SALES CHANNEL AND LEADING SUPPLIER, 2015 (%)
        • TABLE 82 VALUE OF CHINESE VIDARABINE MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
      • Valacyclovir Tablets
      • TABLE 83 VALUE OF CHINESE VALACYCLOVIR TABLET MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
      • FIGURE 27 VALUE OF CHINESE VALACYCLOVIR MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
      • Ganciclovir (Injection)
      • TABLE 84 VALUE OF CHINESE INJECTIVE GANCICLOVIR MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
      • FIGURE 28 VALUE OF CHINESE GANCICLOVIR MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
      • Foscarnet for Injection
      • TABLE 85 VALUE OF CHINESE INJECTIVE FOSCARNET MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
      • FIGURE 29 VALUE OF CHINESE FOSCARNET MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
      • Oseltamivir Tablets
      • TABLE 86 VALUE OF CHINESE OSELTAMIVIR MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
      • FIGURE 30 VALUE OF CHINESE OSELTAMIVIR MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
      • Ribavirin
      • TABLE 87 VALUE OF CHINESE RIBAVIRIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
      • TABLE 31 VALUE OF CHINESE INJECTIVE PIPERACILLIN-TAZOBACTAM MARKET, BY SALES CHANNEL, 2015 ($ MILLIONS/%)

CHAPTER 6 CHINESE INFECTIOUS DISEASE DRUGS BY PRODUCERS

  • TABLE 88 VALUE OF CHINESE INFECTIOUS DISEASE DRUG MARKET BY PRODUCER TYPE, THROUGH 2021 ($ MILLIONS)
  • FIGURE 32 VALUE OF CHINESE INFECTIOUS DISEASE DRUG MARKET BY PRODUCER TYPE, 2015-2021 ($ MILLIONS)
  • TABLE 89 CHINESE INFECTIOUS DISEASE DRUG MARKETBY PRODUCER GROUP, 2015 ($ MILLIONS/%)
  • CHINESE HOMEGROWN DRUGMAKERS
  • TABLE 90 CHINESE HOMEGROWN DRUGMAKERS AND THEIR SALES IN CHINA, 2015 ($ MILLIONS/%)
    • GUANGZHOU PHARMACEUTICAL
    • TABLE 91 GUANGZHOU PHARMACEUTICAL'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)
    • HARBIN PHARMACEUTICAL
    • TABLE 92 HARBIN PHARMACEUTICAL'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)
    • NORTH CHINA PHARMACEUTICAL
    • TABLE 93 NORTH CHINA PHARMACEUTICAL'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)
    • YANGTZE RIVER PHARMACEUTICAL
    • TABLE 94 YANGTZE RIVER PHARMACEUTICAL'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)
    • REYOUNG PHARMACEUTICAL
    • CHIATAI TIANQING
    • TABLE 95 CHIATAI TIANQING'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)
    • HAILINGPHARM
    • TABLE 96 HAILINGPHARM'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)
  • FOREIGN DRUG MARKETS IN THE CHINESE MARKET
  • TABLE 97 CHINESE HOMEGROWN DRUGMAKERS AND THEIR SALES IN CHINA, 2015 ($ MILLIONS/%)
    • PFIZER
    • TABLE 98 PFIZER'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)
    • GSK
    • TABLE 99 GSK'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)
    • MSD
    • TABLE 100 MSD'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)
    • BAYER HEALTHCARE
    • TABLE 101 BAYER HEALTHCARE'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)

CHAPTER 7 THE CHINESE INFECTIOUS DISEASE DRUG MARKET BY SALES CHANNELS

  • TABLE 102 VALUE OF THE CHINESE INFECTIOUS DISEASE DRUG MARKET BY SALES CHANNELS, THROUGH 2021 ($ MILLIONS)
  • FIGURE 33 VALUE OF CHINESE INFECTIOUS DISEASE DRUG MARKET BY SALES CHANNELS, 2015-2021 ($ MILLIONS)
  • CHINESE INFECTIOUS DISEASE DRUGS RETAIL MARKET
    • CHINESE INFECTIOUS DISEASE DRUGS RETAIL MARKET BY RETAILERS
    • TABLE 103 CHINESE RETAIL DRUG MARKET, BY RETAILERS, 2015 ($ MILLIONS/%)
    • CHINESE INFECTIOUS DISEASE DRUGS RETAIL MARKET BY DRUGS
    • TABLE 104 CHINESE RETAIL DRUG MARKET BY DRUG PRODUCT, 2015 ($ MILLIONS/%)
      • Cefixime
      • TABLE 105 CHINESE RETAIL CEFIXIME MARKET BY DRUG FORM, 2015 ($ MILLIONS/%)
      • Entecavir
      • TABLE 106 CHINESE RETAIL ENTERCAVIR MARKET BY DRUG FORM, 2015 ($ MILLIONS/%)
      • Adefovir
      • TABLE 107 CHINESE RETAIL ADEFORVIR MARKET BY DRUG FORM, 2015 ($ MILLIONS/%)
      • CHINESE HOSPITAL MARKET FOR INFECTIOUS DISEASE DRUGS
      • TABLE 108 CHINESE MARKET VALUES OF INFECTIOUS DISEASE DRUGS SOLD IN HOSPITALS BY HOSPITAL TYPE, THROUGH 2021 ($ MILLIONS)
      • TABLE 109 NUMBER OF HOSPITALS IN CHINA BY TYPE, 2015
    • CITY AND COUNTY HOSPITALS
    • TABLE 110 NUMBER OF CITY AND COUNTY HOSPITALS IN CHINA BY TYPE, 2015
    • TABLE 111 NUMBER OF CITY AND COUNTY HOSPITALS IN CHINA BY OWNERSHIP, 2015
    • TOWN AND VILLAGE HOSPITALS
    • TABLE 112 NUMBER OF CITY AND COUNTY HOSPITALS IN CHINA BY TYPE, 2015

CHAPTER 8 CHINESE INFECTIOUS DISEASE DRUG MARKET BY GEOGRAPHY

  • CHINESE GEOGRAPHY
  • CHINESE INFECTIOUS DISEASE DRUG MARKET BY GEOGRAPHY
  • TABLE 113 VALUE OF THE CHINESE INFECTIOUS DISEASE DRUG MARKET BY MAJOR REGION, THROUGH 2021 ($ MILLIONS)
  • FIGURE 34 VALUE OF THE CHINESE COMMUNICABLE INFECTIOUS DISEASE DRUG MARKET BY MAJOR REGION, 2015-2021 ($ MILLIONS)
    • NORTH CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE
    • TABLE 114 VALUES OF THE NORTH CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE, THROUGH 2021 ($ MILLIONS)
    • TABLE 115 VALUES OF INFECTIOUS DISEASE DRUGS, POPULATION AND AVERAGE CONSUMPTION IN NORTH CHINA MARKET BY PROVINCE, 2015 ($ MILLIONS/THOUSANDS/AVERAGE)
    • EAST CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE
    • TABLE 116 VALUES OF THE EAST CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE, THROUGH 2021 ($ MILLIONS)
    • TABLE 117 VALUES OF INFECTIOUS DISEASE DRUGS, POPULATION AND AVERAGE CONSUMPTION IN EAST CHINA MARKET BY PROVINCE, 2015 ($ MILLIONS/THOUSANDS/AVERAGE)
    • SOUTH CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE
    • TABLE 118 VALUES OF THE SOUTH CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE, THROUGH 2021 ($ MILLIONS)
    • TABLE 119 VALUES OF INFECTIOUS DISEASE DRUGS, POPULATION AND AVERAGE CONSUMPTION IN THE SOUTH CHINA MARKET BY PROVINCE, 2015 ($ MILLIONS/THOUSANDS/AVERAGE)
    • MIDDLE CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE
    • TABLE 120 VALUES OF THE MIDDLE CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE, THROUGH 2021 ($ MILLIONS)
    • TABLE 121 VALUES OF INFECTIOUS DISEASE DRUGS, POPULATION AND AVERAGE CONSUMPTION IN THE MIDDLE CHINA MARKET BY PROVINCE, 2015 ($ MILLIONS/THOUSANDS/AVERAGE)
    • NORTHWEST CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE
    • TABLE 122 VALUES OF THE NORTHWEST CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE, THROUGH 2021 ($ MILLIONS)
    • TABLE 123 VALUES OF INFECTIOUS DISEASE DRUGS, POPULATION AND AVERAGE CONSUMPTION IN THE NORTHWEST CHINA MARKET BY PROVINCE, 2015 ($ MILLIONS/THOUSANDS/AVERAGE)
    • SOUTHWEST CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE
    • TABLE 124 VALUES OF THE SOUTHWEST CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE, THROUGH 2021 ($ MILLIONS)
    • TABLE 125 VALUES OF INFECTIOUS DISEASE DRUGS, POPULATION AND AVERAGE CONSUMPTION IN THE SOUTHWEST CHINA MARKET BY PROVINCE, 2015 ($ MILLIONS/THOUSANDS/AVERAGE)
    • NORTHEAST CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE
    • TABLE 126 VALUES OF THE NORTHEAST CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE, THROUGH 2021 ($ MILLIONS)
    • TABLE 127 VALUES OF INFECTIOUS DISEASE DRUGS, POPULATION AND AVERAGE CONSUMPTION IN THE NORTHEAST CHINA MARKET BY PROVINCE, 2015 ($ MILLIONS/THOUSANDS/AVERAGE)
    • CHINESE INFECTIOUS DRUG MARKET BY PROVINCE
    • TABLE 128 VALUE OF THE CHINESE INFECTIOUS DISEASE DRUG MARKET BY MAJOR PRODUCT, THROUGH 2021 ($ MILLIONS)

CHAPTER 9 INDUSTRY STRUCTURE AND MARKET STRATEGIES

  • FIGURE 35 DRUG SUPPLY CHAIN IN CHINA
  • DRUGMAKERS
    • FOREIGN DRUGMAKERS
      • Government Relationship
      • First- and Second-Tier Cities
      • Sales Channels
    • HOMEGROWN DRUGMAKERS
      • Government Relationship
      • Third- and Fourth-Tier Cities
      • Sales Channels
    • DRUG WHOLESALERS
    • DRUG RETAILERS
    • EXCLUSIVE DISTRIBUTORS
    • HOSPITALS
    • RETAILERS
    • END CONSUMERS

CHAPTER 10 COMPANY PROFILES

  • ANHUI BIOCHEM UNITED PHARMACEUTICAL CO. LTD.
  • BAYER CHINA LTD.
  • BEIJING TONG REN TANG
  • BRISTOL-MYERS SQUIBB (CHINA) INVESTMENT CO. LTD.
  • CHIATAI TIANQING PHARMACEUTICAL GROUP CO. LTD.
  • CHINA PHARMACEUTICAL UNIVERSITY PHARMACEUTICAL CO. LTD. (CPU-PHARMA)
  • CHONGQING KERUI PHARMACEUTICAL CO. LTD.
  • CHONGQING LUMMY PHARMACEUTICAL CO. LTD.
  • DASHENLIN
  • DAWNRAYS PHARMACEUTICAL (HOLDINGS) LTD.
    • SUZHOU DAWNRAYS PHARMACEUTICAL CO. LTD.
  • EBANG PHARMACEUTICAL
  • FUJIAN COSUNTER PHARMACEUTICAL CO. LTD.
  • FUREN HUAIQINGTANG PHARMACEUTICAL CO. LTD.
  • GSK CHINA
  • GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDING CO. LTD.
    • BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY
    • GUANGZHOU BAIYUNSHAN TIANXIN PHARMACEUTICAL CO. LTD.
    • GUANGZHOU BAIYUNSHAN GUANGHUA PHARMACEUTICAL CO. LTD.
    • BAIYUNSHAN CHEMICAL PHARMACEUTICAL FACTORY
  • GUODA DRUGSTORE
  • HARBIN PHARMACEUTICAL GROUP HOLDING CO. LTD.
  • HUNAN QIANJIN XIANGJIANG PHARMACEUTICAL INDUSTRY CO. LTD.
  • HUNAN XINHUI PHARMACEUTICAL CO. LTD.
  • JIANGSU WUZHONG PHARMACEUTICAL GROUP CORPORATION
  • KELUN INDUSTRY GROUP & SICHUAN KELUN PHARMACEUTICAL CO. LTD.
  • LUOXIN PHARMACEUTICAL
  • MEDFRON
  • MSD CHINA
  • NORTH CHINA PHARMACEUTICAL GROUP
  • PANBIOTIC
  • PFIZER CHINA
  • QILU PHARMACEUTICAL CO. LTD.
  • QINGFENG PHARMACEUTICAL GROUP
  • REYOUNG PHARMACEUTICAL CO. LTD.
  • ROCHE CHINA
  • RUNDU PHARMA
  • SHANDONG LUKANG PHARMACEUTICAL CO. LTD.
  • SHANDONG RUNZE PHARMACEUTICAL CO. LTD.
  • SUMITOMO PHARMACEUTICALS (SUZHOU) CO. LTD.
  • TUNGSHUN PHARMACEUTICAL
  • WATERSTONE PHARMACEUTICALS
  • YONGNING PHARMA
  • YOUCARE PHARMACEUTICAL GROUP CO. LTD.
  • YUNG SHIN PHARM. IND. (KUNSHAN) CO. LTD.
  • ZHEJIANG HISUN PHARMACEUTICAL CO. LTD.
  • ZHEJIANG MEDICINE CO. LTD.
  • ZHIJUN PHARMACEUTICAL CO. LTD.
  • ZHUHAI UNITED LABORATORIES CO. LTD.

CHAPTER 11 APPENDIX

  • GLOSSARY

LIST OF TABLES

  • SUMMARY TABLE VALUE OF CHINESE INFECTIOUS DISEASE DRUG MARKET, BY DISEASE TYPE, THROUGH 2021 ($ MILLIONS)
  • TABLE 1 VALUE OF CHINESE DRUG END-CONSUMER MARKET, BY SALES CHANNELS, THROUGH 2021 ($ MILLIONS)
  • TABLE 2 VALUE OF THE CHINESE DRUG MARKET BY RETAIL CHANNEL BY DRUG TYPE, THROUGH 2021 ($ MILLIONS)
  • TABLE 3 CHINESE RETAIL TRADITIONAL DRUGS SALES BY MAJOR DRUG TYPE, 2015 ($ MILLIONS/%)
  • TABLE 4 CHINESE RETAIL TRADITIONAL PATENT DRUG SALES BY DRUG TYPE, 2015 ($ MILLIONS/%)
  • TABLE 5 CHINESE RETAIL CHEMICAL AND BIOLOGICAL DRUG SALES BY DRUG TYPE, 2015 ($ MILLIONS/%)
  • TABLE 6 CHINESE DRUG RETAIL SALES BY RETAIL COMPANY, 2015 ($ MILLIONS/%)
  • TABLE 7 VALUE OF THE CHINESE DRUG MARKET IN HOSPITALS, BY DRUG TYPE, THROUGH 2021 ($ MILLIONS)
  • TABLE 8 MARKET SHARES OF CHINESE TRADITIONAL DRUGS SOLD IN HOSPITALS, BY HOSPITAL TYPE AND DRUG TYPE, 2015 (%)
  • TABLE 9 MARKET VALUES OF CHINESE TRADITIONAL DRUGS SOLD IN HOSPITALS, BY HOSPITAL TYPE AND DRUG TYPE, 2015 ($ MILLIONS)
  • TABLE 10 MARKET VALUES OF CHINESE TRADITIONAL DRUGS SOLD IN HOSPITALS, BY HOSPITAL TYPE, THROUGH 2021 ($ MILLIONS)
  • TABLE 11 MARKET SHARES OF CHEMICAL AND BIOLOGICAL DRUGS SOLD IN HOSPITALS BY HOSPITAL TYPE AND DRUG TYPE, 2015 (%)
  • TABLE 12 MARKET VALUE OF CHEMICAL AND BIOLOGICAL DRUGS SOLD IN HOSPITALS IN 2015 BY HOSPITAL TYPE AND DRUG TYPE ($ MILLIONS)
  • TABLE 13 MARKET VALUES OF CHEMICAL AND BIOLOGICAL DRUGS SOLD IN HOSPITALS BY HOSPITAL TYPE, THROUGH 2021 ($ MILLIONS)
  • TABLE 14 VALUE OF THE CHINESE DRUG MARKET BY DRUG TYPE, THROUGH 2021 ($ MILLIONS)
  • TABLE 15 VALUE OF CHINESE TRADITIONAL DRUGS BY SALES CHANNELS THROUGH 2021 ($ MILLIONS)
  • TABLE 16 VALUE OF CHINESE CHEMICAL AND BIOLOGICAL DRUGS BY SALES CHANNELS, THROUGH 2021 ($ MILLIONS)
  • TABLE 17 VALUE OF THE CHINESE INFECTIOUS DISEASE DRUG MARKET BY DISEASE TYPE, THROUGH 2021 ($ MILLIONS)
  • TABLE 18 VALUE OF THE CHINESE COMMUNICABLE INFECTIOUS DISEASE DRUG MARKET BY MAJOR DISEASE TYPE, THROUGH 2021 ($ MILLIONS)
  • TABLE 19 NUMBER OF COMMUNICABLE DISEASES BY MAJOR TYPE IN CHINA, 2015
  • TABLE 20 NUMBER OF CHINESE CATEGORY-A COMMUNICABLE DISEASES BY MAJOR DISEASE, 2015
  • TABLE 21 NUMBER OF CHINESE CATEGORY B COMMUNICABLE DISEASES BY MAJOR DISEASE, 2015
  • TABLE 22 NUMBER OF CHINESE CATEGORY C COMMUNICABLE DISEASES BY MAJOR DISEASE, 2015
  • TABLE 23 VALUE OF CHINESE VIRAL HEPATITIS DRUG MARKET BY MAJOR TYPE, 2015 ($ MILLIONS/%)
  • TABLE 24 VALUE OF CHINESE PULMONARY TUBERCULOSIS DRUG MARKET BY MAJOR TYPE, 2015 ($ MILLIONS/%)
  • TABLE 25 VALUE OF CHINESE INFECTIVE KERATITIS/CONJUNCTIVITIS DRUG MARKET BY MAJOR DRUG TYPE, 2015 ($ MILLIONS/%)
  • TABLE 26 VALUE OF THE CHINESE INFECTIOUS DISEASE DRUG MARKET BY MAJOR PRODUCT, THROUGH 2021 ($ MILLIONS)
  • TABLE 27 VALUE OF THE CHINESE INFECTIOUS DISEASE DRUG MARKET BY MAJOR PRODUCT, THROUGH 2021 ($ MILLIONS)
  • TABLE 28 VALUE OF CHINESE ENTECAVIR MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
  • TABLE 29 CHINESE ENTECAVIR MARKET BY SALES CHANNEL AND LEADING SUPPLIER, 2015 (%)
  • TABLE 30 VALUE OF CHINESE ENTECAVIR MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
  • TABLE 31 VALUE OF CHINESE INJECTIVE PIPERACILLIN-TAZOBACTAM MARKET, BY SALES CHANNEL, 2015 ($ MILLIONS/%)
  • TABLE 32 VALUE OF CHINESE INJECTIVE MEROPENEM MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
  • TABLE 33 VALUE OF CHINESE MEROPENEM MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
  • TABLE 34 VALUE OF CHINESE INJECTIVE CEFPERAZONE-SULBACTAM MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
  • TABLE 35 VALUE OF CHINESE INJECTIVE CEFPERAZONE-SULBACTAM MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
  • TABLE 36 VALUE OF CHINESE LEVOFLOXACIN MARKET BY DRUG FORM, 2015 ($ MILLIONS/%)
  • TABLE 37 VALUE OF CHINESE INJECTIVE LEVOFLOXACIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
  • TABLE 38 VALUE OF CHINESE ORAL LEVOFLOXACIN TABLET MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
  • TABLE 39 VALUE OF CHINESE INJECTIVE LEVOFLOXACIN MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
  • TABLE 40 VALUE OF CHINESE INJECTIVE CEFOPERAZONE-TAZOBACTAM MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
  • TABLE 41 VALUE OF CHINESE CEFUROXIMEE MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
  • TABLE 42 VALUE OF CHINESE INJECTIVE CEFUROXIMEE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
  • TABLE 43 VALUE OF CHINESE INJECTIVE CEFOTIAM MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
  • TABLE 44 VALUE OF CHINESE CEFOTIAM MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
  • TABLE 45 VALUE OF CHINESE INJECTIVE CEFATHIAMIDINE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
  • TABLE 46 VALUE OF CHINESE CEFATHIAMIDINE MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
  • TABLE 47 VALUE OF CHINESE INJECTIVE IMIPENEM/CILASTATIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
  • TABLE 48 VALUE OF CHINESE IMIPENEM/CILASTATIN MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
  • TABLE 49 VALUE OF CHINESE VORICONAZOLE MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
  • TABLE 50 VALUE OF CHINESE INJECTIVE VORICONAZOLE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
  • TABLE 51 VALUE OF CHINESE VORICONAZOLE MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
  • TABLE 52 VALUE OF CHINESE MOXIFLOXACIN MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
  • TABLE 53 VALUE OF CHINESE MOXIFLOXACIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
  • TABLE 54 VALUE OF CHINESE MOXIFLOXACIN MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
  • TABLE 55 VALUE OF CHINESE INJECTIVE CEFOXITIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
  • TABLE 56 VALUE OF CHINESE CEFOXITIN MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
  • TABLE 57 VALUE OF CHINESE INJECTIVE LATAMOXEF MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
  • TABLE 58 VALUE OF CHINESE INJECTIVE LATAMOXEF MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
  • TABLE 59 VALUE OF CHINESE INJECTIVE CEFTRIAXONE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
  • TABLE 60 VALUE OF CHINESE CEFTRIAXONE MARKET BY PRODUCER, 2015 ($ MILLIONS/%)
  • TABLE 61 VALUE OF CHINESE ADEFOVIR MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
  • TABLE 62 CHINESE ADEFOVIR MARKET SHARE BY SALES CHANNEL AND LEADING SUPPLIER, 2015 (%)
  • TABLE 63 VALUE OF CHINESE ADEFOVIR MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
  • TABLE 64 VALUE OF CHINESE LAMIVUDINE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
  • TABLE 65 CHINESE LAMIVUDINE MARKET SHARE BY SALES CHANNEL AND LEADING SUPPLIER, 2015 (%)
  • TABLE 66 VALUE OF CHINESE LAMIVUDINE MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
  • TABLE 67 VALUE OF CHINESE INJECTIVE CEFAZOLIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
  • TABLE 68 VALUE OF CHINESE CEFAZOLIN MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
  • TABLE 69 VALUE OF CHINESE CEFAZOLIN MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
  • TABLE 70 VALUE OF CHINESE INJECTIVE CEFTAZIDIME MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
  • TABLE 71 VALUE OF CHINESE CEFTAZIDIME MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
  • TABLE 72 VALUE OF CHINESE TELBIVUDINE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
  • TABLE 73 VALUE OF CHINESE CEFIXIME MARKET BY DRUG FORM, 2015 ($ MILLIONS/%)
  • TABLE 74 VALUE OF CHINESE CEFIXIME MARKET BY SALES CHANNELS, 2015 ($ MILLIONS/%)
  • TABLE 75 VALUE OF CHINESE AMOXICILLIN-CLAVULANATE MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
  • TABLE 76 VALUE OF CHINESE ITRACONAZOLE MARKET BY DRUG FORMS, 2015 ($ MILLIONS/%)
  • TABLE 77 VALUE OF CHINESE ITRACONAZOLE MARKET BY SALES CHANNELS, 2015 ($ MILLIONS/%)
  • TABLE 78 VALUE OF CHINESE CEFACLOR MARKET BY DRUG FORMS, 2015 ($ MILLIONS/%)
  • TABLE 79 VALUE OF CHINESE CEFACLOR MARKET BY SALES CHANNELS, 2015 ($ MILLIONS/%)
  • TABLE 80 VALUE OF CHINESE VIDARABINE INJECTION MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
  • TABLE 81 CHINESE VIDARABINE MARKET SHARE BY SALES CHANNEL AND LEADING SUPPLIER, 2015 (%)
  • TABLE 82 VALUE OF CHINESE VIDARABINE MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
  • TABLE 83 VALUE OF CHINESE VALACYCLOVIR TABLET MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
  • TABLE 84 VALUE OF CHINESE INJECTIVE GANCICLOVIR MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
  • TABLE 85 VALUE OF CHINESE INJECTIVE FOSCARNET MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
  • TABLE 86 VALUE OF CHINESE OSELTAMIVIR MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
  • TABLE 87 VALUE OF CHINESE RIBAVIRIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
  • TABLE 31 VALUE OF CHINESE INJECTIVE PIPERACILLIN-TAZOBACTAM MARKET, BY SALES CHANNEL, 2015 ($ MILLIONS/%)
  • TABLE 88 VALUE OF CHINESE INFECTIOUS DISEASE DRUG MARKET BY PRODUCER TYPE, THROUGH 2021 ($ MILLIONS)
  • TABLE 89 CHINESE INFECTIOUS DISEASE DRUG MARKETBY PRODUCER GROUP, 2015 ($ MILLIONS/%)
  • TABLE 90 CHINESE HOMEGROWN DRUGMAKERS AND THEIR SALES IN CHINA, 2015 ($ MILLIONS/%)
  • TABLE 91 GUANGZHOU PHARMACEUTICAL'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)
  • TABLE 92 HARBIN PHARMACEUTICAL'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)
  • TABLE 93 NORTH CHINA PHARMACEUTICAL'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)
  • TABLE 94 YANGTZE RIVER PHARMACEUTICAL'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)
  • TABLE 95 CHIATAI TIANQING'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)
  • TABLE 96 HAILINGPHARM'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)
  • TABLE 97 CHINESE HOMEGROWN DRUGMAKERS AND THEIR SALES IN CHINA, 2015 ($ MILLIONS/%)
  • TABLE 98 PFIZER'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)
  • TABLE 99 GSK'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)
  • TABLE 100 MSD'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)
  • TABLE 101 BAYER HEALTHCARE'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)
  • TABLE 102 VALUE OF THE CHINESE INFECTIOUS DISEASE DRUG MARKET BY SALES CHANNELS, THROUGH 2021 ($ MILLIONS)
  • TABLE 103 CHINESE RETAIL DRUG MARKET, BY RETAILERS, 2015 ($ MILLIONS/%)
  • TABLE 104 CHINESE RETAIL DRUG MARKET BY DRUG PRODUCT, 2015 ($ MILLIONS/%)
  • TABLE 105 CHINESE RETAIL CEFIXIME MARKET BY DRUG FORM, 2015 ($ MILLIONS/%)
  • TABLE 106 CHINESE RETAIL ENTERCAVIR MARKET BY DRUG FORM, 2015 ($ MILLIONS/%)
  • TABLE 107 CHINESE RETAIL ADEFORVIR MARKET BY DRUG FORM, 2015 ($ MILLIONS/%)
  • TABLE 108 CHINESE MARKET VALUES OF INFECTIOUS DISEASE DRUGS SOLD IN HOSPITALS BY HOSPITAL TYPE, THROUGH 2021 ($ MILLIONS)
  • TABLE 109 NUMBER OF HOSPITALS IN CHINA BY TYPE, 2015
  • TABLE 110 NUMBER OF CITY AND COUNTY HOSPITALS IN CHINA BY TYPE, 2015
  • TABLE 111 NUMBER OF CITY AND COUNTY HOSPITALS IN CHINA BY OWNERSHIP, 2015
  • TABLE 112 NUMBER OF CITY AND COUNTY HOSPITALS IN CHINA BY TYPE, 2015
  • TABLE 113 VALUE OF THE CHINESE INFECTIOUS DISEASE DRUG MARKET BY MAJOR REGION, THROUGH 2021 ($ MILLIONS)
  • TABLE 114 VALUES OF THE NORTH CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE, THROUGH 2021 ($ MILLIONS)
  • TABLE 115 VALUES OF INFECTIOUS DISEASE DRUGS, POPULATION AND AVERAGE CONSUMPTION IN NORTH CHINA MARKET BY PROVINCE, 2015 ($ MILLIONS/THOUSANDS/AVERAGE)
  • TABLE 116 VALUES OF THE EAST CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE, THROUGH 2021 ($ MILLIONS)
  • TABLE 117 VALUES OF INFECTIOUS DISEASE DRUGS, POPULATION AND AVERAGE CONSUMPTION IN EAST CHINA MARKET BY PROVINCE, 2015 ($ MILLIONS/THOUSANDS/AVERAGE)
  • TABLE 118 VALUES OF THE SOUTH CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE, THROUGH 2021 ($ MILLIONS)
  • TABLE 119 VALUES OF INFECTIOUS DISEASE DRUGS, POPULATION AND AVERAGE CONSUMPTION IN THE SOUTH CHINA MARKET BY PROVINCE, 2015 ($ MILLIONS/THOUSANDS/AVERAGE)
  • TABLE 120 VALUES OF THE MIDDLE CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE, THROUGH 2021 ($ MILLIONS)
  • TABLE 121 VALUES OF INFECTIOUS DISEASE DRUGS, POPULATION AND AVERAGE CONSUMPTION IN THE MIDDLE CHINA MARKET BY PROVINCE, 2015 ($ MILLIONS/THOUSANDS/AVERAGE)
  • TABLE 122 VALUES OF THE NORTHWEST CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE, THROUGH 2021 ($ MILLIONS)
  • TABLE 123 VALUES OF INFECTIOUS DISEASE DRUGS, POPULATION AND AVERAGE CONSUMPTION IN THE NORTHWEST CHINA MARKET BY PROVINCE, 2015 ($ MILLIONS/THOUSANDS/AVERAGE)
  • TABLE 124 VALUES OF THE SOUTHWEST CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE, THROUGH 2021 ($ MILLIONS)
  • TABLE 125 VALUES OF INFECTIOUS DISEASE DRUGS, POPULATION AND AVERAGE CONSUMPTION IN THE SOUTHWEST CHINA MARKET BY PROVINCE, 2015 ($ MILLIONS/THOUSANDS/AVERAGE)
  • TABLE 126 VALUES OF THE NORTHEAST CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE, THROUGH 2021 ($ MILLIONS)
  • TABLE 127 VALUES OF INFECTIOUS DISEASE DRUGS, POPULATION AND AVERAGE CONSUMPTION IN THE NORTHEAST CHINA MARKET BY PROVINCE, 2015 ($ MILLIONS/THOUSANDS/AVERAGE)
  • TABLE 128 VALUE OF THE CHINESE INFECTIOUS DISEASE DRUG MARKET BY MAJOR PRODUCT, THROUGH 2021 ($ MILLIONS)

LIST OF FIGURES

  • SUMMARY FIGURE VALUE OF CHINESE INFECTIOUS DISEASE DRUG MARKET, BY DISEASE TYPE, 2015-2021 ($ MILLIONS)
  • FIGURE 1 VALUE OF CHINESE DRUG END-CONSUMER MARKET, BY SALES CHANNELS, 2015-2021 ($ MILLIONS)
  • FIGURE 2 DRUG SUPPLY CHAIN IN CHINA
  • FIGURE 3 VALUE OF THE CHINESE COMMUNICABLE INFECTIOUS DISEASE DRUG MARKET BY MAJOR DISEASE TYPE, 2015-2021 ($ MILLIONS)
  • FIGURE 4 VALUE OF THE CHINESE COMMUNICABLE INFECTIOUS DISEASE DRUG MARKET BY MAJOR DISEASE TYPE, 2015-2021 ($ MILLIONS)
  • FIGURE 5 VALUE OF THE CHINESE COMMUNICABLE INFECTIOUS DISEASE DRUG MARKET BY MAJOR DISEASE TYPE, 2015-2021 ($ MILLIONS)
  • FIGURE 6 VALUE OF CHINESE ENTECAVIR MARKET BY SALES CHANNEL, 2015 (%)
  • FIGURE 7 VALUE OF CHINESE INJECTIVE PIPERACILLIN-TAZOBACTAM MARKET, BY SALES CHANNEL, 2015 (%)
  • FIGURE 8 VALUE OF CHINESE INJECTIVE MEROPENEM MARKET BY SALES CHANNEL, 2015 (%)
  • FIGURE 9 VALUE OF CHINESE INJECTIVE CEFPERAZONE-SULBACTAM MARKET BY SALES CHANNEL, 2015 (%)
  • FIGURE 10 VALUE OF CHINESE INJECTIVE LEVOFLOXACIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
  • FIGURE 11 VALUE OF CHINESE INJECTIVE CEFOPERAZONE-TAZOBACTAM MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
  • FIGURE 12 VALUE OF CHINESE INJECTIVE CEFUROXIME MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
  • FIGURE 13 VALUE OF CHINESE INJECTIVE CEFOTIAM MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
  • FIGURE 14 VALUE OF CHINESE INJECTIVE CEFATHIAMIDINE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
  • FIGURE 15 VALUE OF CHINESE INJECTIVE IMIPENEM/CILASTATIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
  • FIGURE 16 VALUE OF CHINESE INJECTIVE VORICONAZOLE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
  • FIGURE 17 VALUE OF CHINESE MOXIFLOXACIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
  • FIGURE 18 VALUE OF CHINESE INJECTIVE CEFOXITIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
  • FIGURE 19 VALUE OF CHINESE INJECTIVE LATAMOXEF MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
  • FIGURE 20 VALUE OF CHINESE INJECTIVE CEFTRIAXONE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
  • FIGURE 21 VALUE OF CHINESE ADEFOVIR MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
  • FIGURE 22 VALUE OF CHINESE LAMIVUDINE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
  • FIGURE 23 VALUE OF CHINESE INJECTIVE CEFAZOLIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
  • FIGURE 24 VALUE OF CHINESE INJECTIVE CEFTAZIDIME MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
  • FIGURE 25 VALUE OF CHINESE TELBIVUDINE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
  • FIGURE 26 VALUE OF CHINESE VIDARABINE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
  • FIGURE 27 VALUE OF CHINESE VALACYCLOVIR MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
  • FIGURE 28 VALUE OF CHINESE GANCICLOVIR MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
  • FIGURE 29 VALUE OF CHINESE FOSCARNET MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
  • FIGURE 30 VALUE OF CHINESE OSELTAMIVIR MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
  • FIGURE 32 VALUE OF CHINESE INFECTIOUS DISEASE DRUG MARKET BY PRODUCER TYPE, 2015-2021 ($ MILLIONS)
  • FIGURE 33 VALUE OF CHINESE INFECTIOUS DISEASE DRUG MARKET BY SALES CHANNELS, 2015-2021 ($ MILLIONS)
  • FIGURE 34 VALUE OF THE CHINESE COMMUNICABLE INFECTIOUS DISEASE DRUG MARKET BY MAJOR REGION, 2015-2021 ($ MILLIONS)
  • FIGURE 35 DRUG SUPPLY CHAIN IN CHINA
Back to Top